Polar Securities »

Celldex Therapeutics shares owned by Polar Securities

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Polar Securities from 13F filings

Historical chart of Polar Securities investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Polar Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Polar Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.7M 94k 39.66
2023-09-30 $3.6M 132k 27.52
2022-06-30 $2.7M 99k 26.96
2022-03-31 $2.4M 69k 34.06

More positions owned by Polar Securities

Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
United States Stl Corp Note 5.000%11/0 (Principal)
Intuitive Surgical Com New (ISRG)
Sprott Physical Gold Tr Unit (PHYS)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ati Note 3.500% 6/1 (Principal)
Interdigital Note 3.500% 6/0 (Principal)
Bloomin Brands Note 5.000% 5/0 (Principal)
Ormat Technologies Note 2.500% 7/1 (Principal)
Boston Scientific Corporation (BSX)
Ishares Tr Ishares Semicdtr Put Option (SOXX)
Post Hldgs Note 2.500% 8/1 (Principal)
Sony Group Corp Sponsored Adr Put Option (SONY)

View all positions for Polar Securities

Top funds holding Celldex Therapeutics

Wellington Management Company
Eventide Asset Management
Vanguard Group
Kynam Capital Management
Point72 Asset Management
Bellevue Group
Marshall Wace
Redmile Group
Octagon Capital Advisors
Commodore Capital
Jennison Associates
Charles Schwab Investment Management
5AM Venture Management
Goldman Sachs Group
Sphera Funds Management

View all funds holding Celldex Therapeutics